Manufacturer of Controlled Substances; Notice of Application, 22844 [2010-10116]

Download as PDF 22844 Federal Register / Vol. 75, No. 83 / Friday, April 30, 2010 / Notices (2) Title of the Form/Collection: 2009 Census of Publicly Funded Forensic Crime Laboratories. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: The form number is CFCL–1, Bureau of Justice Statistics, Office of Justice Programs, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Respondents will represent Federal, State, and local governments. This information collection is a census of public crime laboratories that perform forensic analyses on criminal evidence. The information will provide statistics on laboratories’ capacity to analyze forensic crime evidence, the number, types, and sources of evidence received per year, and the number, types, and cost of analyses completed. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 405 respondents will complete a 4.1 hour form. (6) An estimate of the total public burden (in hours) associated with the collection: The total hour burden to complete the data collection is 1,660.5 annual burden hours. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Information Management and Security Staff, Justice Management Division, Suite 1600, Patrick Henry Building, 601 D Street, NW., Washington, DC 20530. Drug Schedule Raw Opium (9600) ....................... Poppy Straw (9650) ..................... Concentrate of Poppy Straw (9670). II II II The company plans to import the listed controlled substances to manufacture bulk controlled substance intermediates for sale to its customers. As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate. As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: April 26, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–10115 Filed 4–29–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Dated: April 27, 2010. Lynn Bryant, Department Clearance Officer, PRA, United States Department of Justice. Drug Enforcement Administration [FR Doc. 2010–10142 Filed 4–29–10; 8:45 am] Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 16, 2010, Lonza Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: BILLING CODE 4410–18–P DEPARTMENT OF JUSTICE Drug Enforcement Administration wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1 Importer of Controlled Substances; Notice of Application This is notice that on March 15, 2010, Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II. Drug Schedule Coca Leaves (9040) ..................... VerDate Mar<15>2010 13:41 Apr 29, 2010 II Jkt 220001 Manufacturer of Controlled Substances; Notice of Application Drug Schedule Gamma hydroxybutyric acid (2010). Amphetamine (1100) .................... Methylphenidate (1724) ................ I II II The company plans to manufacture bulk active pharmaceutical ingredients (APIs) for distribution to its customers. PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than June 29, 2010. Dated: April 26, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010–10116 Filed 4–29–10; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Occupational Safety and Health Administration [Docket No. OSHA–2010–0008] Construction Fall Protection Systems Criteria and Practices and Training Requirements; Extension of the Office of Management and Budget’s (OMB) Approval of Information Collection (Paperwork) Requirements AGENCY: Occupational Safety and Health Administration (OSHA), Labor. ACTION: Request for public comment. SUMMARY: OSHA solicits public comments concerning its proposal to extend OMB approval of the information collection requirements contained in the construction standards on Fall Protection Systems Criteria and Practices (29 CFR 1926.502) and Training Requirements (29 CFR 1926.503). DATES: Comments must be submitted (postmarked, sent, or received) by June 29, 2010. ADDRESSES: Electronically: You may submit comments and attachments electronically at https:// www.regulations.gov, which is the Federal eRulemaking Portal. Follow the instructions online for submitting comments. Facsimile: If your comments, including attachments, are not longer than 10 pages, you may fax them to the OSHA Docket Office at (202) 693–1648. Mail, hand delivery, express mail, messenger, or courier service: When using this method, you must submit three copies of your comments and attachments to the OSHA Docket Office, E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 75, Number 83 (Friday, April 30, 2010)]
[Notices]
[Page 22844]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-10116]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 16, 2010, Lonza 
Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)...........  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk active pharmaceutical 
ingredients (APIs) for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 29, 2010.

    Dated: April 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-10116 Filed 4-29-10; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.